SR9009 30mL 20mg/mL

Description

About SR9009 (Stenabolic): REV-ERBα and REV-ERBβ nuclear receptors are transcriptional repressors that coordinate circadian rhythm and metabolic pathways in a heme-dependent manner. SR9009 is a REV-ERB agonist that increases the constitutive repression of genes regulated by REV-ERBα and REV-ERBβ with IC₅₀ values of 670 and 800 nM, respectively.¹

Through activation of REV-ERB, SR9009 has been shown to decrease circadian locomotor activity during the dark phase and to alter the expression pattern of core clock genes in the hypothalami of mice.¹ The circadian pattern of expression of an array of metabolic genes in the liver, skeletal muscle and adipose tissue was also shown to be altered in mice exposed to SR9009, resulting in increased energy expenditure.¹

Diet-induced obese mice treated with 100 mg/kg SR9009 (i.p. two times a day for 30 days) have been reported to display decreased fat mass and markedly improved dyslipidemia and hyperglycemia.¹

BUY SR9009 Solution Today from GenX Peptides.

We offer the highest grade and purity of SR9009 for sale at a competitive price in the USA. For best results buy SR9009 liquid solution of the highest quality from GenX Peptides.

For more information on SR9009 please visit Pubmed.

References & Product Citations

Concentration: 20mg per mL, 600mg/30mL

• Description

---

Read the Specification Before Buying:

Application	A potent agonist of Rev-ErbA
CAS	1379686-30-2
Molar Mass	437.94 g/mol
Chemical Formula	C20H24ClN3O4S
Chemical Name	ethyl 3-[[(4-chlorophenyl)methyl-[(5-nitrothiophen-2-yl)methyl]amino]methyl]pyrrolidine-1-carboxylate
Synonyms	SR9009, SR-9009, SR 9009, Stenabolic
Storage	Room temperature
Solubility	Ethanol, DMSO
Organoleptic Profile	Clear & yellow Liquid
Physical Form	Solution in Glycerin, PEG400, ethanol (less than 0.5%)
Safety Information	For Research Only. Not for Diagnostic or Therapeutic use